Skip to main content
. 2019 Aug 30;7(3):66. doi: 10.3390/biomedicines7030066

Figure 1.

Figure 1

Patients with first diagnosis of primary GBM were treated with Standard therapy including multimodal immunotherapy. The details of the patients have been published [142]. An updated overall survival curve of this cohort of patients, 14 months later, is presented. The difference to the earlier calculation is due to the later time point of analysis.